Revisiting complete response in light chain amyloidosis.
作者信息
Sidana Surbhi, Dispenzieri Angela, Murray David L, Go Ronald S, Buadi Francis K, Lacy Martha Q, Gonsalves Wilson I, Dingli David, Warsame Rahma, Kourelis Taxiarchis, Muchtar Eli, Hayman Suzanne R, Kapoor Prashant, Kyle Robert A, Leung Nelson, Rajkumar S Vincent, Gertz Morie A, Kumar Shaji K
机构信息
Division of Blood and Marrow Transplantation, Stanford University, Stanford, CA, USA.
Division of Hematology, Mayo Clinic, Rochester, MN, USA.
出版信息
Leukemia. 2020 May;34(5):1472-1475. doi: 10.1038/s41375-019-0664-9. Epub 2019 Nov 26.
Abstract
摘要
相似文献
1
Revisiting complete response in light chain amyloidosis.
Leukemia. 2020 May;34(5):1472-1475. doi: 10.1038/s41375-019-0664-9. Epub 2019 Nov 26.
2
IgM AL amyloidosis: delineating disease biology and outcomes with clinical, genomic and bone marrow morphological features.
Leukemia. 2020 May;34(5):1373-1382. doi: 10.1038/s41375-019-0667-6. Epub 2019 Nov 28.
3
Outcome of Patients With Newly Diagnosed Systemic Light-Chain Amyloidosis Associated With Deletion of 17p.
Clin Lymphoma Myeloma Leuk. 2018 Nov;18(11):e493-e499. doi: 10.1016/j.clml.2018.07.292. Epub 2018 Jul 25.
4
High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.
Br J Haematol. 2004 Dec;127(5):543-51. doi: 10.1111/j.1365-2141.2004.05232.x.
5
Clinical presentation and prognosis of immunoglobulin light-chain amyloidosis with high percentage of bone marrow plasma cells.
Leuk Res. 2019 Jun;81:19-24. doi: 10.1016/j.leukres.2019.04.002. Epub 2019 Apr 8.
6
7
Treatment With Bortezomib-based Therapy, Followed by Autologous Stem Cell Transplantation, Improves Outcomes in Light Chain Amyloidosis: A Retrospective Study.
Clin Lymphoma Myeloma Leuk. 2018 Jul;18(7):486-492.e1. doi: 10.1016/j.clml.2018.04.006. Epub 2018 May 4.
8
Severity and reversibility of cardiac dysfunction and residual concentration of amyloidogenic light chain predict overall survival of patients with AL amyloidosis who attain complete response.
Amyloid. 2017 Mar;24(sup1):54-55. doi: 10.1080/13506129.2017.1289916.
9
Stringent patient selection improves outcomes in systemic light-chain amyloidosis after autologous stem cell transplantation in the upfront and relapsed setting.
Haematologica. 2014 Dec;99(12):e260-3. doi: 10.3324/haematol.2014.108191. Epub 2014 Sep 5.
10
Immunoparesis status in AL amyloidosis at diagnosis affects response and survival by regimen type.
Amyloid. 2017 Mar;24(sup1):44-45. doi: 10.1080/13506129.2017.1281117.
引用本文的文献
1
Early minimal residual disease eradication in light chain amyloidosis generates deeper and faster cardiac response.
Clin Exp Med. 2024 Nov 1;24(1):250. doi: 10.1007/s10238-024-01511-z.
2
Autologous stem cell transplantation in AL amyloidosis: Muddy waters.
Blood Rev. 2024 Nov;68:101228. doi: 10.1016/j.blre.2024.101228. Epub 2024 Aug 10.
3
Treatment patterns and outcomes in light chain amyloidosis: An institutional registry of amyloidosis report in Argentina.
PLoS One. 2022 Oct 27;17(10):e0274578. doi: 10.1371/journal.pone.0274578. eCollection 2022.
4
Light Chain Stabilization: A Therapeutic Approach to Ameliorate AL Amyloidosis.
Hemato. 2021 Dec;2(4):645-659. doi: 10.3390/hemato2040042. Epub 2021 Oct 5.
5
Adding Cyclophosphamide to Bortezomib and Dexamethasone was not Associated With Improved Outcomes of Patients With Newly Diagnosed Light Chain Amyloidosis: A Retrospective Study.
Clin Lymphoma Myeloma Leuk. 2022 Aug;22(8):e770-e776. doi: 10.1016/j.clml.2022.04.003. Epub 2022 Apr 8.
6
Detection of minimal residual disease by next generation sequencing in AL amyloidosis.
Blood Cancer J. 2021 Jun 21;11(6):117. doi: 10.1038/s41408-021-00511-6.
7
Minimal residual disease negativity by next-generation flow cytometry is associated with improved organ response in AL amyloidosis.
Blood Cancer J. 2021 Feb 16;11(2):34. doi: 10.1038/s41408-021-00428-0.
8
Involved free light chains <10 mg/L with treatment predict better outcomes in systemic light-chain amyloidosis.
Am J Hematol. 2021 Jan;96(1):E20-E23. doi: 10.1002/ajh.26025. Epub 2020 Nov 5.
Zotero 插件